Biographica
PrivateLast Round
Seed
Jan 7, 2026
Total Funding Raised
$9.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Biographica operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in January 2026.
Biographica is an agricultural biotechnology company that has developed a genomics platform using proprietary molecular data and a multi-modal graph-centric approach to identify and prioritize high-value targets for crop gene editing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biographica Comparables
Compare Biographica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heritable Agriculture | 85% | |
| Phytoform Labs | 85% | |
| Rainbow Crops | 82% |
For institutional investors. Book with your work email.
Biographica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 7, 2026 | ||||
| Pre Seed | Sep 3, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biographica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nucleus Capital | Seed, Pre Seed |
| Saras Capital | Seed, Pre Seed |
| EQT Foundation | Seed |
| Ventures Together | Seed, Pre Seed |
| Ventures Together | Seed |
| Dhyan Ventures | Seed |
| Sie Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 308% MoM, reaching 2.8K.
- Aug 15, 2026
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 30, 2026
Biographica Ltd introduces CROP-1 on Oct 30th '26, an AI model that combines DNA sequence information with biological context to predict gene behavior across conditions and support the development of more resilient crops.
- recognized_asOct 16, 2026
Biographica Ltd is selected for the Norrsken 100, a list of companies tackling deep-tech problems at scale, and its name appears in Times Square to mark the recognition.
- partners_withSep 21, 2026
Biographica Ltd and Hudson River partner to take crop trait development from causal-gene discovery through transgene-free, genetically uniform edited plants, starting with tomato and expanding to vegetables and soft fruit.
- partners_withSep 21, 2026
Biographica Ltd and Stewart Grain Co. partner on crop genome editing, combining a computational platform for identifying high-value gene targets with gene-editing expertise, on Sep 21st '26.
For institutional investors. Book with your work email.
Biographica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biographica's valuation, stock price, and market status.
Is Biographica a public or private company?
Biographica is a private company.
What is the current stock price of Biographica?
Biographica is a private company, so its shares have no public market price. Caplight tracks Biographica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biographica worth (valuation)?
Valuation information for Biographica is not publicly available.
Can I buy Biographica stock?
Biographica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biographica's last funding round?
Biographica's most recent funding round was Seed on January 7, 2026.
Who are the main investors in Biographica?
Key investors in Biographica include Faber Ventures.
Will Biographica IPO soon?
No public IPO plans have been announced for Biographica.
How can I track Biographica secondary market activity?
Caplight tracks bids, offers, and trades in Biographica's shares on secondary markets.